The efficacy of Origanum majorana nanocubosomal systems in ameliorating submandibular salivary gland alterations in streptozotocin-induced diabetic rats
Open Access
- 29 December 2021
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 62-74
Abstract
Diabetes mellitus is a challenging health problem. Salivary gland dysfunction is one of its complications. Current treatments possess numerous adverse effects. Therefore, herbal extracts have emerged as a promising approach for safe and effective treatment. However, they are required in large doses to achieve the desired effect. Accordingly, Origanum majorana extract (OE) was incorporated into nano-sized systems to enhance its biological effects at lower dosages. OE was standardized against rosmarinic acid (RA) and then loaded into nano-cubosomal (NC) systems via a 23 full-factorial design. Two optimum nano-systems at different drug loads (2.08 or 1.04 mg-RA/mL) were selected and assessed in vivo to compare their effects in streptozotocin-induced diabetic rats against conventional OE (2.08 mg-RA/mL). Blood glucose was evaluated weekly. Submandibular salivary glands were processed for histopathological examination and nuclear factor-erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), and p38-MAPK gene expression analysis. NC systems were successfully prepared and optimized where the optimum systems showed nano-sized vesicles (210.4–368.3 nm) and high zeta potential values. In vivo results showed a significant lower blood glucose in all treated groups, with an exceptional reduction with NC formulations. Marked histopathological improvement was observed in all OE-treated groups, with OE-NC4 (2.08 mg-RA/mL) demonstrating the best features. This was supported by RT-PCR; where the OE-NC4 group recorded the highest mean value of Nrf2 and the least mean values of Keap1 and p38-MAPK, followed by OE-NC3 and OE groups. In conclusion, OE-loaded NC enhanced the anti-hyperglycemic effect of OE and ameliorated diabetic gland alterations compared to conventional OE. Thus, cubosomal nano-systems could be anticipated as potential carriers for the best outcome with OE.Keywords
This publication has 70 references indexed in Scilit:
- Anesthetic regimen for cardiac function evaluation by echocardiography in mice: comparison between ketamine, etomidate and isoflurane versus conscious stateLaboratory Animals, 2013
- Transcription Factor Nrf2-Mediated Antioxidant Defense System in the Development of Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2013
- A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®International Journal of Nanomedicine, 2012
- Harnessing the potential clinical use of medicinal plants as anti-diabetic agentsBotanics: Targets and Therapy, 2012
- Formulation of Dacarbazine-Loaded Cubosomes—Part I: Influence of Formulation VariablesAAPS PharmSciTech, 2009
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriersColloids and Surfaces A: Physicochemical and Engineering Aspects, 2008
- Differential regulation and properties of MAPKsOncogene, 2007
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Antibacterial Screening ofOriganum majoranaL. Oil from TunisiaJournal of Essential Oil Research, 2001